Ineffectiveness and toxicity of BCG vaccine for the prevention of recurrent genital herpes

about

Antigenic breadth: a missing ingredient in HSV-2 subunit vaccines?Vaccine Therapy for Herpes Simplex Virus Infections: An Historical Perspective.

P2860

Q38212516-29C3084C-59B7-49FE-8858-068309E5E2D5 Q45748526-FAC0565B-9000-4949-A1E5-F3A2F0FCE9E5

P2860

Ineffectiveness and toxicity of BCG vaccine for the prevention of recurrent genital herpes

Item

http://www.wikidata.org/entity/Q35569595

description

1985 nî lūn-bûn

@nan

1985年の論文

@ja

1985年論文

@yue

1985年論文

@zh-hant

1985年論文

@zh-hk

1985年論文

@zh-mo

1985年論文

@zh-tw

1985年论文

@wuu

1985年论文

@zh

1985年论文

@zh-cn

name

Ineffectiveness and toxicity o ...... on of recurrent genital herpes

@ast

Ineffectiveness and toxicity o ...... on of recurrent genital herpes

@en

type

Item

label

Ineffectiveness and toxicity o ...... on of recurrent genital herpes

@ast

Ineffectiveness and toxicity o ...... on of recurrent genital herpes

@en

prefLabel

Ineffectiveness and toxicity o ...... on of recurrent genital herpes

@ast

Ineffectiveness and toxicity o ...... on of recurrent genital herpes

@en

P1476

Ineffectiveness and toxicity o ...... on of recurrent genital herpes

@en

P2093

C Critchlow

http://www.w3.org/2001/XMLSchema#string

J M Douglas

http://www.w3.org/2001/XMLSchema#string

K K Holmes

http://www.w3.org/2001/XMLSchema#string

L A Vontver

http://www.w3.org/2001/XMLSchema#string

L Corey

http://www.w3.org/2001/XMLSchema#string

M L Remington

http://www.w3.org/2001/XMLSchema#string

W C Reeves

http://www.w3.org/2001/XMLSchema#string

W E Stamm

http://www.w3.org/2001/XMLSchema#string

P2860

Resistance of female mice to vaginal infection induced by Herpesvirus hominis type 2: effects of immunization with Mycobacterium bovis, intravenous injection of specific Herpesvirus hominis type 2 antiserum, and a combination of these procedures.

Isolation of viruses, bacteria and other organisms from venereal disease clinic patients: methodology and problems associated with multiple isolations.

Herpes simplex infections in hematologic malignancies.

BCG and cancer.

BCG immunoprophylaxis of recurrent herpes progenitalis.

Use of immunoperoxidase for rapid diagnosis of mucocutaneous herpes simplex virus infection.

Genital herpes simplex virus infections: clinical manifestations, course, and complications.

BCG-induced suppressor cells. I. Demonstration of a macrophage-like suppressor cell that inhibits cytotoxic T cell generation in vitro.

Suppressed or enhanced antibody responses in vitro after BCG treatment of mice: importance of BCG viability.

Immunopotentiation with BCG. I. Immune response to different strains and preparations.

P304

203-206

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.27.2.203

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

1985-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

3885848

http://www.w3.org/2001/XMLSchema#string

P932

176238

http://www.w3.org/2001/XMLSchema#string

Ineffectiveness and toxicity of BCG vaccine for the prevention of recurrent genital herpes

about

P2860

P2860

Ineffectiveness and toxicity of BCG vaccine for the prevention of recurrent genital herpes

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932